永崇高囊在患有轻度至重度COPD的患者中的有效性:多中心,随机,主动受控试验
Suyun Li1,2,3, Yang Xie1,2,3, Lin Lin4
1Department of Respiratory Diseases, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, China.
与保释囊 (BLC) 相比,永崇高囊 (YChCC) 在慢性阻塞性肺病 (COPD) 患者中显著降低了急性恶化. YChCC疗法为管理稳定的COPD提供了潜在的好处,从轻度到重度的阶段.
科学领域:
- 呼吸系统医学 呼吸系统医学
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 慢性阻塞性肺病 (COPD) 是一个主要的全球健康问题.
- 保释囊 (BLC) 和永崇高囊 (YChCC) 是中国传统药物,用于治疗COPD的成分相似.
- YChCC受益于先进的种植和大规模生产.
研究的目的:
- 系统地比较YChCC和BLC在轻度至重度COPD患者的治疗效果.
- 评估YChCC作为稳定的COPD辅助疗法的疗效.
主要方法:
- 一个多中心,随机,主动控制的试验,涉及240名COPD患者.
- 患者接受YChCC或BLC治疗24周,随后进行24周的随访.
- 主要终点:急性恶化的数量. 二级终点包括肺功能,呼吸障碍和生活质量得分.
主要成果:
- 与BLC相比,YChCC显著降低了急性恶化病例的数量 (p < 0.003).
- YChCC延长了第一个急性恶化的时间.
- 两组之间没有发现肺功能或生活质量得分的显著差异.
结论:
- YChCC在减少COPD患者急性恶化方面表现出显著的有效性.
- YChCC代表了一种有前途的辅助疗法,用于跨重症谱的稳定COPD的管理.
- 这些发现表明YChCC在改善COPD管理结果方面具有潜在的益处.
更多相关视频
07:10Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
04:03Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
Published on: September 27, 2024
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-I: Introduction
